Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Aberer

Showing results (21-30 of 95) with videos related to

Pageof 10
Sort By:
Biosensors|May 26, 2026
Glycemic Efficacy and Safety by Using Insulin Degludec and Aspart Guided by a Clinical Decision Support System in Non-Critically Ill Inpatients with Type 2 Diabetes MellitusFelix Aberer, Daniel A Hochfellner, Petra M Baumann, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|October 19, 2022
Blood glucose response to running or cycling in individuals with type 1 diabetes: A systematic review and meta-analysisMax L Eckstein, Faisal Aziz, Felix Aberer, et al.
Journal of Diabetes Science and Technology|February 12, 2015
Novel simple insulin delivery device reduces barriers to insulin therapy in type 2 diabetes: results from a pilot studyNorbert Hermanns, Leslie C Lilly, Julia K Mader, et al.
Biomedicines|March 28, 2026
Clinical Characteristics and Predictors of Glycemic Control During the First 24 Months After Diagnosis of Type 1 DiabetesSelina Löffler, Fabio Frigo, Daniel Hochfellner, et al.
Diabetes Care|March 7, 2014
A feasibility study of a 3-day basal-bolus insulin delivery device in individuals with type 2 diabetesJulia K Mader, Leslie C Lilly, Felix Aberer, et al.
BMC Endocrine Disorders|April 27, 2021
Adverse body composition and lipid parameters in patients with prolactinoma: a case-control studyAnna Sophia Posawetz, Christian Trummer, Marlene Pandis, et al.
Diabetes, Obesity & Metabolism|March 17, 2025
Impact of level 2 hypoglycaemia on neuroaxonal damage biomarker in individuals with type 2 diabetes: A stepwise hypoglycaemic clamp studyHarald Sourij, Kehkishan Azhar, Felix Aberer, et al.
Metabolites|April 28, 2023
Acute Fluid Intake Impacts Assessment of Body Composition via Bioelectrical Impedance Analysis. A Randomized, Controlled Crossover Pilot TrialJanis Schierbauer, Svenja Günther, Sandra Haupt, et al.
Pediatric Endocrinology, Diabetes, and Metabolism|February 18, 2025
Performance of real-time continuous glucose monitoring during track and field training in adolescents with type 1 diabetesRebecca T Zimmer, Felix Aberer, Janis Schierbauer, et al.
Sensors (Basel, Switzerland)|July 27, 2024
Glycemic Control Assessed by Intermittently Scanned Glucose Monitoring in Type 1 Diabetes during the COVID-19 Pandemic in AustriaKatharina Secco, Petra Martina Baumann, Tina Pöttler, et al.
Pageof 10

Showing results (21-30 of 95) with videos related to

Sort By:
Pageof 10
Biosensors|May 26, 2026
Glycemic Efficacy and Safety by Using Insulin Degludec and Aspart Guided by a Clinical Decision Support System in Non-Critically Ill Inpatients with Type 2 Diabetes MellitusFelix Aberer, Daniel A Hochfellner, Petra M Baumann, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|October 19, 2022
Blood glucose response to running or cycling in individuals with type 1 diabetes: A systematic review and meta-analysisMax L Eckstein, Faisal Aziz, Felix Aberer, et al.
Journal of Diabetes Science and Technology|February 12, 2015
Novel simple insulin delivery device reduces barriers to insulin therapy in type 2 diabetes: results from a pilot studyNorbert Hermanns, Leslie C Lilly, Julia K Mader, et al.
Biomedicines|March 28, 2026
Clinical Characteristics and Predictors of Glycemic Control During the First 24 Months After Diagnosis of Type 1 DiabetesSelina Löffler, Fabio Frigo, Daniel Hochfellner, et al.
Diabetes Care|March 7, 2014
A feasibility study of a 3-day basal-bolus insulin delivery device in individuals with type 2 diabetesJulia K Mader, Leslie C Lilly, Felix Aberer, et al.
BMC Endocrine Disorders|April 27, 2021
Adverse body composition and lipid parameters in patients with prolactinoma: a case-control studyAnna Sophia Posawetz, Christian Trummer, Marlene Pandis, et al.
Diabetes, Obesity & Metabolism|March 17, 2025
Impact of level 2 hypoglycaemia on neuroaxonal damage biomarker in individuals with type 2 diabetes: A stepwise hypoglycaemic clamp studyHarald Sourij, Kehkishan Azhar, Felix Aberer, et al.
Metabolites|April 28, 2023
Acute Fluid Intake Impacts Assessment of Body Composition via Bioelectrical Impedance Analysis. A Randomized, Controlled Crossover Pilot TrialJanis Schierbauer, Svenja Günther, Sandra Haupt, et al.
Pediatric Endocrinology, Diabetes, and Metabolism|February 18, 2025
Performance of real-time continuous glucose monitoring during track and field training in adolescents with type 1 diabetesRebecca T Zimmer, Felix Aberer, Janis Schierbauer, et al.
Sensors (Basel, Switzerland)|July 27, 2024
Glycemic Control Assessed by Intermittently Scanned Glucose Monitoring in Type 1 Diabetes during the COVID-19 Pandemic in AustriaKatharina Secco, Petra Martina Baumann, Tina Pöttler, et al.
Pageof 10